DYNAVAX INITIATES PHASE 3 TRIAL FOR HEPATITIS B VACCINE.: An article from: Biotech Business
Price
USD
$5.95
This digital document is an article from Biotech Business, published by Worldwide Videotex on August 1, 2005. The length of the article is 1065 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: DYNAVAX INITIATES PHASE 3 TRIAL FOR HEPATITIS B VACCINE.
Publication: Biotech Business (Newsletter)
Date: August 1, 2005
Publisher: Worldwide Videotex
Volume: 18 Issue: 8 Page: NA
Distributed by Thomson Gale